Literature DB >> 33596205

Robust COX-2-mediated prostaglandin response may drive arthralgia and bone destruction in patients with chronic inflammation post-chikungunya.

Yosra Bedoui1,2, Axelle Septembre-Malaterre3, Claude Giry4, Marie-Christine Jaffar-Bandjee4, Jimmy Selambarom1, Pascale Guiraud1, Philippe Gasque1,2.   

Abstract

Patients following infection by chikungunya virus (CHIKV) can suffer for months to years from arthralgia and arthritis. Interestingly, methotrexate (MTX) a major immune-regulatory drug has proved to be of clinical benefit. We have previously shown that CHIKV can persist in the joint of one patient 18 months post-infection and plausibly driving chronic joint inflammation but through ill-characterized mechanisms. We have pursued our investigations and report novel histological and in vitro data arguing for a plausible role of a COX-2-mediated inflammatory response post-CHIKV. In the joint, we found a robust COX-2 staining on endothelial cells, synovial fibroblasts and more prominently on multinucleated giant cells identified as CD11c+ osteoclasts known to be involved in bone destruction. The joint tissue was also strongly stained for CD3, CD8, CD45, CD14, CD68, CD31, CD34, MMP2, and VEGF (but not for NO synthase and two B cell markers). Dendritic cells were rarely detected. Primary human synovial fibroblasts were infected with CHIKV or stimulated either by the synthetic molecule polyriboinosinic:polyribocytidylic acid (PIC) to mimic chronic viral infection or cytokines. First, we found that PIC and CHIKV enhanced mRNA expression of COX-2. We further found that PIC but not CHIKV increased the mRNA levels of cPLA2α and of mPGES-1, two other central enzymes in PGE2 production. IFNβ upregulated cPLA2α and COX-2 transcription levels but failed to modulated mPGES-1 mRNA expression. Moreover, PIC, CHIKV and IFNβ decreased mRNA expression of the PGE2 degrading enzyme 15-PGDH. Interestingly, MTX failed to control the expression of all these enzymes. In sharp contrast, dexamethasone was able to control the capacity of pro-inflammatory cytokines, IL-1β as well as TNFα, to stimulate mRNA levels of cPLA2α, COX-2 and mPGES-1. These original data argue for a concerted action of CHIKV (including viral RNA) and cytokines plausibly released from recruited leukocytes to drive a major COX-2-mediated PGE2 proinflammatory responses to induce viral arthritis.

Entities:  

Year:  2021        PMID: 33596205      PMCID: PMC7920362          DOI: 10.1371/journal.pntd.0009115

Source DB:  PubMed          Journal:  PLoS Negl Trop Dis        ISSN: 1935-2727


  59 in total

1.  Coordinate up- and down-regulation of glutathione-dependent prostaglandin E synthase and cyclooxygenase-2 in A549 cells. Inhibition by NS-398 and leukotriene C4.

Authors:  S Thorén; P J Jakobsson
Journal:  Eur J Biochem       Date:  2000-11

2.  Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages.

Authors:  Karine Labadie; Thibaut Larcher; Christophe Joubert; Abdelkrim Mannioui; Benoit Delache; Patricia Brochard; Lydie Guigand; Laurence Dubreil; Pierre Lebon; Bernard Verrier; Xavier de Lamballerie; Andreas Suhrbier; Yan Cherel; Roger Le Grand; Pierre Roques
Journal:  J Clin Invest       Date:  2010-02-22       Impact factor: 14.808

3.  Low dose methotrexate decreases intraarticular prostaglandin and interleukin 1 levels in antigen induced arthritis in rabbits.

Authors:  G S Novaes; S B Mello; I M Laurindo; W Cossermelli
Journal:  J Rheumatol       Date:  1996-12       Impact factor: 4.666

4.  TLR3-dependent induction of nitric oxide synthase in RAW 264.7 macrophage-like cells via a cytosolic phospholipase A2/cyclooxygenase-2 pathway.

Authors:  José Pindado; Jesús Balsinde; María A Balboa
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

5.  Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients.

Authors:  Gianandrea Borgherini; Patrice Poubeau; Frederik Staikowsky; Manuella Lory; Nathalie Le Moullec; Jean Philippe Becquart; Catherine Wengling; Alain Michault; Fabrice Paganin
Journal:  Clin Infect Dis       Date:  2007-04-18       Impact factor: 9.079

6.  Coordinate regulation of TLR-mediated arachidonic acid mobilization in macrophages by group IVA and group V phospholipase A2s.

Authors:  Violeta Ruipérez; Alma M Astudillo; María A Balboa; Jesús Balsinde
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

7.  The toll-like receptor 3 ligand, poly(I:C), improves immunosuppressive function and therapeutic effect of mesenchymal stem cells on sepsis via inhibiting MiR-143.

Authors:  Xiaoyin Zhao; Dan Liu; Wei Gong; Guangfeng Zhao; Liu Liu; Liu Yang; Yayi Hou
Journal:  Stem Cells       Date:  2014-02       Impact factor: 6.277

Review 8.  Arthritogenic alphaviruses--an overview.

Authors:  Andreas Suhrbier; Marie-Christine Jaffar-Bandjee; Philippe Gasque
Journal:  Nat Rev Rheumatol       Date:  2012-05-08       Impact factor: 20.543

Review 9.  Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia.

Authors:  Laurence Dupuis-Maguiraga; Marion Noret; Sonia Brun; Roger Le Grand; Gabriel Gras; Pierre Roques
Journal:  PLoS Negl Trop Dis       Date:  2012-03-27

10.  Immunomodulatory drug methotrexate used to treat patients with chronic inflammatory rheumatisms post-chikungunya does not impair the synovial antiviral and bone repair responses.

Authors:  Yosra Bedoui; Claude Giry; Marie-Christine Jaffar-Bandjee; Jimmy Selambarom; Pascale Guiraud; Philippe Gasque
Journal:  PLoS Negl Trop Dis       Date:  2018-08-03
View more
  2 in total

Review 1.  Decrypting the cellular and molecular intricacies associated with COVID-19-induced chronic pain.

Authors:  Mousmi Rani; Ankit Uniyal; Vinod Tiwari
Journal:  Metab Brain Dis       Date:  2022-07-18       Impact factor: 3.655

2.  MBZM-N-IBT, a Novel Small Molecule, Restricts Chikungunya Virus Infection by Targeting nsP2 Protease Activity In Vitro, In Vivo, and Ex Vivo.

Authors:  Soumyajit Ghosh; Supriya Suman Keshry; Bharat Bhusan Subudhi; Soma Chattopadhyay; Saikat De; Chandan Mahish; Chinmayee Mohapatra; Ankeeta Guru; Prabhudutta Mamidi; Ankita Datey; Sweta Smita Pani; Dileep Vasudevan; Tushar Kant Beuria; Subhasis Chattopadhyay
Journal:  Antimicrob Agents Chemother       Date:  2022-06-29       Impact factor: 5.938

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.